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Cytotoxic drugs tend to have substantial side effects on healthy tissues leading to systemic toxicity, limited tolerated doses and 
reduced drug efficacy. A prominent research area focuses on encapsulating cytotoxic drugs for targeted delivery to cancer tissues. 
However, existing carriers suffer from low drug loading levels and high drug leaching high both when circulating systemically and 
when accumulating in non-target organs. These challenges mean that the few approved encapsulation technologies have not been 
widely adopted for clinical use. Recently, we have demonstrated efficient manufacture of impermeable metal-shell/liquid core 
microcapsules that permit localised delivery by triggering release with ultrasound. This method has the potential to improve on 
existing methods for localised drug delivery because it:  
 Encapsulates high concentrations of low molecular weight hydrophobic drugs; 
 Preventing leaching in non-target areas resulting in the possibility of drastically amplifying the enhanced permeability and 
retention (EPR) effect; 
 Allows triggered release via ultrasound to deliver high drug doses locally 
 
We demonstrate here the further miniaturization of both the emulsion droplet template and the thickness of the surrounding metal 
shell to the nanoscale in an attempt to take advantage of the EPR effect and allow for the excretion of the nanoparticles by the 
hepatobiliary system. 
1.1 Introduction 
The design and fabrication of nanoscale drug delivery 
systems (nanocarriers) to allow controllable encapsulation 
and release of therapeutic agents within the body has received 
a great deal of interest in the literature.[1-11] A particularly 
prominent research area focuses on the encapsulation of small 
cytotoxic drugs for intravenous delivery to cancer tissues.[12-
14] Targeted encapsulation can allow for more efficient 
delivery to tumours than that achieved when the free drug is 
circulated systemically, thereby reducing off-target side-
effects with potential increased efficacy. Consequently, 
encapsulation also has the potential of locally delivering 
higher drug concentrations for the same initial dose. 
Numerous technologies have been proposed academically to 
achieve safer/more efficient chemotherapeutic drug delivery. 
Many rely on particulate-based drug carriers, which often 
take advantage of the EPR effect, a form of passive targeting, 
to allow the nanocarrier to preferentially accumulate at the 
tumour site. However, these carriers typically only achieve 
small improvements in efficacy as compared to systemic 
drivery of the free drug, often because drug leaching, 
particulary into non-targeted organs such as the liver, kidney 
and spleen,[12] is not prevented and therefore systemic 
toxicity is not averted,[9] particularly on dilution into the 
blood stream.[12] These drawbacks, in conjunction with the 
relatively weak EPR effect have, in part, contributed to very 
few nanocarriers being approved for transition to clinical 
practice.[13, 14] 
 
In the last 15 years or so, localised triggered delivery 
methods[15-20] in combination with improved 
nanocarriers[10, 12] showing more efficient drug retention 
have offered hope of increasing drug dosage locally while 
reducing systemic side effects. Several triggering methods 
have been proposed to actively release drugs at the site of the 
tumours, in particular photothermal[15] or acoustic[19] 
methods, which enable remote activation of the drug carriers 
to release their cargo locally[16-20]. More recently, drug 
carriers where metal films/shells are used to provide a low 
permeability barrier show great promise in improving drug 
retention before release is activated. Indeed, such systems 
typically take advantage of the very low diffusion of drug 
molecules through the metal but also rely on their structural 
properties to allow induced fracture and consequently trigger 
the drug release. Sun et al. showed activated release from 
metal capsules using an ultrasonic probe however the 
colloidosome template based metal shell growth technique 
currently limits capsules to the micron size range.[21] Wang 
et al were able to synthesis metal nanocapsules based on 
polymeric vesicle templates and used near infra-red light to 
induce capsule rupture.[9] Although direct evidence of 
leakage free nanocapsules was not demonstrated, in-vivo 
mouse work was evidenced. 
 
Figure 1. Schematic diagrams and examples of corresponding electron micrographs of 
the three synthesis steps leading to the preparation of metal capsules: (1) catalytic 
platinum nanoparticles (Pt-NPs) stabilised by a long chain polymer are first 
synthesised (2) the nanoparticles are then used to stabilise liquid emulsion droplets 
containing the dissolved drug to be encapsulated (a nanodroplet here was chosen to 
exemplify the surface position of individual PtNPs) and (3) an electroless deposition 
process is carried out to deposit a continuous, impermeable metal coating on the 
emulsion droplet to fully encapsulate the droplet core containing the drug. 
 
Metal-shell nanocapsules could significantly improve 
existing delivery mechanisms as they have the potential for 
indefinitely retaining high doses of chemotherapy drugs, 
restricting systemic drug leaching[9] in other tissues known 
to accumulate nanoparticles[12] whilst allowing for safe 
build-up of drugs in tumours through the EPR effect before 
releasing high drug doses controllably using triggered release. 
This unique release profile coupled with extended 
capsule/carrier residency times (100 nm gold particle 
clearance times are more than 6 months[22-24]) could 
potentially provide an opportunity to amplify the weak EPR 
effect, extending drug delivery efficacy far beyond existing 
carriers.[25]  
In addition metal nanocapsules are good ultrasound contrast 
agents[16, 25-27], which could also allow for image guided 
theranostics, important for ascertaining nanocapsule position 
and concentration prior to capsule rupturing using focused 
ultrasound. They also show low biological toxicity[23, 28] 
and are easily surface functionalised.[29] Previously 
demonstrated phased metal shell fracture[30] could also 
potentially allow for the administration of a single dose 
followed by multiple phased release of drug.  
Recently, we have demonstrated the efficient manufacture of 
impermeable metal-shell/liquid core microcapsules[31] 
(Figure 1) that allow localised high dose delivery of small 
molecular actives by remotely triggering release with 
ultrasound at the target location.[30, 32] In this work, we use 
a metal film deposition process, where first platinum 
nanoparticles (Pt-NPs) are used to stabilise emulsion droplets, 
thus creating micron sized oil droplets with a dense packing 
of nanoparticles on their surface. Secondly, the adsorbed 
nanoparticles are used as catalysts/nucleation sites at the oil-
water interface for the electroless deposition of a continuous 
secondary metal film on the surface of the oil droplets. 
Previously, the resulting metal-shell microcapsules prepared 
with this method have been limited to a size range of 
approximately 500 nm to 20 m, which although potentially 
appropriate for implantation in resection cavities, is not 
appropriate for systemic drug delivery.  
This article translates the previous work described above 
towards much smaller impermeable metal-shell 
nanocapsules. Here we explore the possibility of reliably 
producing a Pt-NP stabilised nanoemulsion template with 
high particle density at the oil-water interface for use as a 
template for  secondary metal film growth. The production of 
metal capsules from these nanoemulsion droplet precursors is 
then explored. Finally, we investigate the retention of a small 
model molecule within the capsules. 
1.2 Materials and methods 
Materials 
The following chemicals were used as received: polyvinyl 
pyrrolidone (PVP, 40kDa, Fluka Analytical, >99%), Sodium 
tetrahydridoborate (NaBH4, Sigma Aldrich, ≥98.0%), 
chloroplatinic acid hydrate (H2PtCl6-6 H2O, Sigma Aldrich, 
≥99.9% trace metals basis), gold (III) chloride tetrahydrate 
(HAuCl4·3H2O, Sigma Aldrich, 99.99% trace metals basis), 
hexadecane (Sigma Aldrich, 99%), sunflower oil (Sigma 
Aldrich 99.99%), hydrogen peroxide (Sigma Aldrich H2O2, 
30.5 wt%) and Paclitaxel (Taxus brevifolia, Fluorochem). 
Milli-Q water (18.2 MΩ.cm resistivity at 25°C) was obtained 
from a Millipore unit and used throughout all experiments. 
Platinum nanoparticle synthesis 
Pt-NPs were synthesised by the reduction of platinum salt in 
the presence of a reducing agent, Sodium tetrahydridoborate, 
at room temperature. H2PtCl6.6H2O (0.23 g, 4.4 mM) was 
dissolved in a 0.0067 wt% PVP solution (100 mL). Under 
vigorous stirring, NaBH4 (2 mL (1.2 M) was rapidly added 
into the mixture which was accompanied by a rapid change 
in colour from yellow to black. After stirring at 750 rpm for 
2 minutes the nanoparticle suspension was filtered through a 
0.2 µm pore size syringe filter, in order to remove any larger 
contaminates, and stored at 4 oC.  
Gold film growth on platinum nanoparticles in suspension 
To test the possibility of controlling the electroless deposition 
of very thin secondary metal films onto the Pt NPs, different 
gold film thicknesses were deposited on the surface of Pt-NPs 
when suspended in an aqueous continuous phase. This was 
achieved through the following method: 0.05 mL of the 
undiluted Pt-NP dispersion (synthesis described above) was 
added to Milli-Q water (10 mL). 1 mL of a PVP solution (40 
KDa 0.05 wt%) and 0.025 – 1 mL of a 12 mM gold salt 
solution (HAuCl4) were added successively. The volume of 
gold salt added to the suspension was varied depending on the 
desired final core/shell nanoparticle diameter. Finally, 1 mL 
of H2O2 (60 mM) was added to initiate the electroless 
deposition process and the vial was gently mixed by hand for 
30 seconds. 
Emulsification 
Hexadecane (volumes ranging from 0.01 - 0.4 mL) was added 
to the Pt-NP dispersion (5 mL) and immediately pre-
emulsified by vigorously shaking the sample by hand for 
approximately 5 seconds. The pre-emulsion was then 
homogenised using a Sonic Dismembrator Ultrasonic 
Processor (Model FB-505 Fisher Scientific) for 1 minute at 
20% amplitude. A water bath at ambient temperature, 
(~20°C), was used to limit temperature increase of the 
emulsion during homogenisation whilst not causing the 
hexadecane to freeze (hexadecane melting point is 18°C). The 
resulting emulsions were then agitated on a carousel for 3 
minutes and used subsequently without further processing. 
In order to produce emulsions containing Paclitaxel, excess 
Paclitaxel was left to dissolve in sunflower oil for 24 hours 
and then filtered to remove undissolved drug (Giving a final 
solution concentration of ~13 mg.mL-1). The emulsification 
step was then carried out using 0.4 mL of oil in the same way 
as described above for the hexadecane core Pickering 
emulsions.  
Electroless deposition of metal shell 
For both the hexadecane and the Paclitaxel in sunflower oil 
Pt-NP stabilised micron sized Pickering emulsions, 0.2 mL of 
undiluted Pickering emulsion was added to the following gold 
plating solution; 1 mL PVP solution (0.2wt%), 10mL of 
Milli-Q water, 2 mL of 12 mM gold salt (HAuCl4) and 1 mL 
of H2O2 (60 mM). The samples were then agitated on the 
carousel for 30 minutes. Capsules were then allowed to settle 
under gravity for 24 hours and were subsequently washed by 
removal and replacement of the supernatant with Milli-Q 
water.  
The nano-sized Pickering emulsions were metal coated by 
adding 0.05 mL of a homogeneously mixed Pickering 
emulsion (made with 0.01 mL of hexadecane) to the same 
plating solution as described above apart from the volume of 
the gold salt solution (12 mM), which was varied from 0.025 
to 2 mL depending on the desired film thickness. In order to 
keep the plating volume the same, samples using a lower 
volume of gold salt were topped up to the constant total 
volume used throughout these procedures with Milli-Q water. 
Characterisation  
Optical microscopy: Microcapsules were observed using an 
Olympus BX51 optical microscope. 
Emulsion size distribution measurements: For sub-micron 
emulsion droplets, a NanoSeries Zetasiser (Malvern Nano-
ZS) (DLS) fitted with a He-Ne laser source (633 nm 
wavelength, 4 mW power) was used to measure droplet size 
distribution. For emulsion droplets larger than 1 m, droplet 
size distribution was measured using a Benchtop C70 Series 
FlowCAM imaging flow cytometry instrument used in 
AutoImage mode with a 20x objective, FC50 flow cell in a 
reverse flow configuration to ensure that all droplets are 
passed through the measurement cell. 
Scanning electron microscopy (SEM): a LEO 1530 Gemini 
field emission gun scanning electron microscopy (FEGSEM) 
was used to image metal-shell microcapsules. No conductive 
coating is applied for these observations. 
Transmission electron microscopy (TEM and CryoTEM): 
Nanoparticle samples were analysed using a FEI Tecnai TF20 
field emission transmission gun electron microscope 
(FEGTEM) fitted with a HAADF detector and GatanOrius 
SC600A CCD camera. An Oxford Instruments INCA 350 
EDX system/80 mm X-Max SDD detector was used for 
elemental mapping. Prior to analysis, samples were deposited 
on a TEM grid (holey carbon film, 400 Cu Mesh from Agar 
Scientific) and allowed to dry. It should be noted that this 
method only takes account of the metallic nanoparticle cores 
and not the PVP polymer ‘shell’, an example of one such 
image can be found in figure 8.  Particle sizes where then 
determined using ImageJ software using the following 
method: TEM images were first adjusted for contrast, the 
threshold size was then set to a surface area 2−28 nm2, and 
the circularity was set to 0.2−1.00. The resulting image was 
then made binary and the particle diameters were 
automatically analysed to give a size distribution for the 
suspension. 
Nano-sized Pickering emulsion droplets were imaged using 
an FEI Titan3 Themis G2 Cryo-TEM operating at 300kV 
fitted with 4 EDX silicon drift detectors and a Gatan One-
View CCD.  For cryo-EDX spectroscopy, Bruker Esprit v1.9 
software was used along with probe currents between 40 and 
100 pA and a dwell time of 23 μs.  High angle annular dark 
field scanning transmission electron scanning mode was used 
(HAADF STEM). 0.1 mL of suspension was allowed to flow 
through a lacey carbon coated TEM grid (EM Resolutions) 
onto a blotting tissue underneath the grid. Samples were then 
immediately (to avoid complete drying of the sample) blotted 
(blot force 6) and plunged into liquid ethane. A Gatan 914 
cryo-holder was used and the temperature was maintained 
below -160°C to prevent devitrification. 
 
The same Cryo-TEM procedure was used to measure Pt-NP 
densities at Pickering emulsion droplet interfaces. Pickering 
emulsion droplets were made binary in colour, manually 
using ArtStudio (5.103). The binary images were then 
analysed for surface area coverage using ImageJ software and 
apparent nanoparticle surface densities were corrected for 
emulsion drop curvature. Both methods are described in a 
previous publication.[33] 
  
Hexadecane core retention testing using gas 
chromatograpy (GC) 
100% of the gold coated capsule dispersion was allowed to 
settle under gravity for 48 hours (Settling rates increase 
dramatically between the nano-Pickering emulsions and the 
corresponding thickest (15-20 nm) gold shell nanocapsules 
due to a combination of both a significant increase in mean 
density due to the gold (19.3 gcm3) and increased diameter). 
The water above the capsules was removed and the sample 
was replenished with Milli-Q water to reach a total volume of 
2 mL. 8 mL of absolute ethanol was then added to yield a 
capsule suspension in a 4:1 ethanol:water continuous phase. 
The capsules were periodically gently stirred and 1.5 mL 
samples was taken and centrifuged at 7000 rpm for 1 minute 
(Eppendorf Minispin) to remove the capsules by 
sedimentation. The supernatant was analysed with a Perkin 
Elmer Clarus 580GC using the following method and 
column: Elite-1 capillary column, length 30 m, internal 
diameter 0.25 mm. The column temperature was programmed 
from 50°C to 300°C at 20°C/min at a flow rate of 2 mL/min. 
Paclitaxel retention testing using high pressure liquid 
chromatography–mass spectrometry and UV detector 
(HPLC-MS-UV) 
Release of paclitaxel from microcapsules was measured as 
follows. Firstly, all of the gold coated microcapsules were 
allowed to settle under gravity for 2 hours (sedimentation 
rates of the capsules were calculated – see figure 6 and 
equation 1 - in order to confirm this time was sufficient). The 
water above the capsules was removed and the suspension 
was replenished with Milli-Q water for a total volume of 2 
mL. The maximum solubility of paclitaxel in the discarded 
aqueous supernatant is negligible meaning that the potential 
effect of losses incurred in the aqueous phase on the 
measurement process is also negligible. 8 mL of acetonitrile 
was then added to obtain a suspension in a 4:1 ratio of 
acetonitrile to water. 
 
The capsules were then periodically, gently stirred and 1.5 
mL samples were taken and centrifuged at 7000 rpm for 1 
minute (Eppendorf Minispin) to remove the capsules by 
sedimentation. The supernatant was then analysed using 
HPLC. Release from the control, uncoated Pickering 
emulsion, against which the previous samples were 
normalized, was tested as follows. 0.2 mL of the re-dispersed 
Pickering emulsion was added to 1.8 mL of Milli-Q water and 
8 mL of acetonitrile. The vial was then periodically, gently 
stirred and 1 mL samples were taken and centrifuged at 7000 
rpm for 1 minute to remove any platinum nanoparticles by 
sedimentation. It should be noted that on dissolution of the 
Sunflower oil core from the Pickering emulsions, the 
platinum nanoparticle stabilising ‘sheets’ aggregate in the 
acetonitrile and therefore sediment well under the centrifugal 
conditions described above. The supernatant was then 
analysed by HPLC. For both samples, the mobile phase was 
acetonitrile/water, with a gradient of 5-90 % acetonitrile over 
5 minutes and a flow rate of 0.5 mL/min. The column used 
was an Ascentis Express C18, 50 x 2.1 mm with a 2.7 m 
particle size. UV detection was measured at 230 nm 
wavelength.  
1.3 Results and discussion 
The work presented in this article builds on our previous 
studies that demonstrated control of metal-shell microcapsule 
physical properties such as size, shell thickness and core 
type.[30-32] In addition, our recent work demonstrated direct 
growth of a gold film on the surface of emulsion droplets 
stabilised by nanoparticles which act as a nucleation site for 
an electroless deposition process. Remotely triggering metal 
shell fracture using ultrasound was also shown to be 
achievable to activate core release.[30] Here, we further 
demonstrate (i) encapsulation of a cytotoxic drug in such 
metal-shell microcapsules and (ii) development of metal-shell 
nanocapsules with sizes suitable for (leaching-free) systemic 
delivery. Thus, we first aim to confirm that metal-shell 
microcapsules, of mean diameter ~10 µm and shell thickness 
~50 nm, are able to permanently encapsulate Paclitaxel, a 
typical chemotherapy drug of the taxane family, which is used 
in treatment of many common cancers including breast 
cancer. For this purpose, we emulsified 0.4 mL of sunflower 
oil containing Paclitaxel at a concentration of ~13 mg.mL-1 
with 5mL of a Pt-NP aqueous dispersion. The resulting 
oil/water Pickering emulsion droplets were metal coated and 
tested for release/leaching of the drug in an acetonitrile/water 
continuous phase chosen to enable complete dissolution of 
the encapsulated drug if leaching occurs (see method section 
for full description). We then monitored the percentage of 
Paclitaxel remaining encapsulated over time (Figure 2). 
 
Figure 2: Drug release monitored over time via HPLC for ( ) the 
uncoated Pickering emulsion used as a permeable carrier control and for     
( ) metal-shell microcapsules into a phase in which the core readily 
dissolves (80% acetonitrile, 20% water).  ( ) - represents the subsequent 
paclitaxel release activated with an ultrasonic probe. 
Figure 2 confirms that Paclitaxel in a sunflower oil carrier can 
be encapsulated, in a metal shell, without leaching in an 
acetonitrile continuous phase, which readily dissolves both 
core species. The capsules were able to retain, without 
leakage, ~90% of the core phase over at least 16 hours. The 
subsequent core release method using mechanical fracture via 
ultrasonic probe (see methods for details) does not recover all 
of the encapsulated Paclitaxel. This is likely for two reasons: 
a) A proportion of the capsules remain unbroken; and, b) 
Paclitaxel adsorbs onto metal capsule fragments, which are 
removed during the centrifugation before characterising the 
concentration of drug present in the sample continuous phase. 
Production of nanoscale Pickering emulsions 
In order to produce liquid core metal capsules, which can be 
used as intravenous drug delivery vehicles, able to take 
advantage of the EPR effect and be excreted by the biliary 
system, the metal-shell capsules need to be approximately 
100 nm in diameter.[34, 35] As a result, the size of the initial 
emulsion droplet templates needs to be reduced to such 
dimensions, while retaining a high particle density at the oil-
water interface. We therefore used the same optimised Pt-NP 
dispersion in order to avoid competitive interfacial adsorption 
of excess PVP polymer during emulsification.[33] We then 
used ultrasonic probe homogenisation and manipulated the 
emulsion oil-to-water ratio in order to reduce the resulting oil 
droplet size. 
Figure 3 shows the obtained Pickering emulsions, 10 hours 
after emulsification, when hexadecane, used here again as a 
model oil, was homogenised with the Pt-NP aqueous 
dispersion using different oil/water ratios. All samples were 
homogenised with an ultrasonic probe for 1 min at 20% 
power amplitude. As demonstrated in a  previous publication 
for larger droplets,[30] reducing the oil volume fraction in 
these emulsions leads to a decrease in droplet diameter, which 
is here manifested by both a change in the droplet creaming 
rate (Figure 3) and in the droplet sizes (Figure 4). Here, the 
droplet total surface area remains approximately constant 
independently of the oil volume fraction (Figure 5) and thus 
the droplets increase in size as the oil volume fraction is 
increased. This is a result of (almost) all the nanoparticles 
adsorbing at the oil/water interface to stabilise the emulsion 
(as demonstrated by the high light transmittance of the 
creamed emulsion continuous phase) and a process of limited 
coalescence driving full particle coverage at the interface. 
Both of these phenomena have been discussed 
previously.[30] 
 
Figure 3: Digital photographs of Pt-NPs-stabilised emulsions for different 
oil volume ratios: a) 8 vol%, b) 4 vol%, c) 2 vol%, d) 1 vol%, e) 0.4 vol% 
and f) 0.2 vol%. All samples are shown 10 hours after preparation (1 min 
ultrasonic homogenisation at 20% amplitude). 5 mL of Pt-NP dispersion as 
the aqueous continuous phase was used in each case. 
Figure 4 shows the resulting mean emulsion droplet sizes as 
a function of oil to continuous phase volume ratio. Droplets 
of diameter more than 1 µm were measured by optical 
microscopy by analysing a large number of images of the 
dispersion as it flows through a microfluidic channel 
(Flowcam). Droplets of diameters below 500 nm were 
measured by dynamic light scattering (DLS) (Zetasizer). 
 
Figure 4: Mean emulsion droplet size as a function of oil/water 
(hexadecane / Pt-NP dispersion) phase ratio.  The continuous line 
represents the theoretical droplet size as a function of total volume of oil in 
the sample calculated using the (constant) expected total surface area the 
Pt-NPs are able to cover which itself is based on CryoTEM imaging. 2D Pt-
NP surface density was measured to be ~34% and is denoted as β in 
equation S3 in the supplementary information (see cryo-TEM methods 
section for the experimental description) 
Figure 4 demonstrates that, by using an optimized Pt-NP 
dispersion[33] and altering the ratio of the dispersed phase 
(core oil) to the continuous phase (Pt-NPs aqueous 
dispersion), the mean size of the resulting emulsion droplets 
can be tuned from approximately 10 µm down to the 100 nm 
target diameter and below. The fitted line represents the 
theoretical droplet size as a function of oil volume present in 
the emulsions using the total surface area the Pt-NPs are able 
to cover as measured via cryo-TEM from the emulsion 
samples (NPs surface coverage was measured as ~34% and is 
denoted as β in equation S3 in the supplementary 
information). The improved fit at higher dispersed phase 
volume ratios is possibly due to some level of dispersed phase 
loss to the vial surface at the very low volumes (high oil/Pt-
NP volume ratios).  
To characterise further these emulsion droplets, two 
particular oil volume ratios were studied, namely 8% and 
0.4%, for which large droplets above 1 m and small droplets 
around 100 nm are formed, respectively. Optical microscopy 
was used to observe the larger droplets, which showed typical 
structures for this particular system (Figure 5a). However, for 
the smaller droplets, it was necessary to use Cryo-TEM to 
perform the same experiment, which consequently also 
allowed for the position and density of the Pt-NPs stabilisers 
to be identified (Figure 5b). 
 
 
Figure 5: (a) Optical micrograph of Pt-NP stabilised  Pickering emulsion 
droplets, the inset shows the size distribution (measured by Flowcam). Oil 
to continuous phase volume fraction was 8% and (b) shows a cryo-HAADF 
STEM micrograph of Pt-NP stabilised Pickering emulsion droplets of d50 
~100 nm , the inset shows the size distribution measured by dynamic light 
scattering. Oil to continuous phase volume ratio was 0.4%. In both cases 
the ultrasonic probe homogeniser was used to prepare the emulsions at a 
power of 20% for 1 min.  
Nano-sized Pickering emulsion droplet size measurements 
showed a D50 of 108 nm, with a relatively broad size 
distribution highlighting the presence of some larger droplets, 
which were not suitable for the intended drug delivery 
purposes. As a consequence, the smaller emulsion droplets 
need to be isolated for further use. Thus, in the following 
sections, the 2D nanoparticle density is characterised with a 
view to primarily growing very thin impermeable secondary 
metal films but also assessing emulsion droplet buoyancy to 
explore the potential of purification by centrifugation. 
Nano-Pickering emulsion buoyancy and 2D nanoparticle 
surface density 
In addition to providing essential information used to tightly 
control secondary metal film growth, understanding 2D 
platinum nanoparticle density provides insight into the 
Pickering emulsion properties and subsequent metal-shell 
capsules settling behaviour. For a particular core, 
(hexadecane in this case), it is possible to use this information 
to isolate the smaller capsules within a suspension through 
size selection using centrifugation. Figure 6 shows calculated 
buoyancy relative to the density of water as a function of 
emulsion droplet diameter for the primary Pickering emulsion 
and metal capsules of several different metal film thicknesses. 
 
Figure 6: shows calculated buoyancy relative to water as a function of 
diameter for the primary Pickering emulsion (  ) and metal capsules of 
various anticipated metal film thicknesses, 2 nm (  ), 5 nm (  ), 10 nm (  
) and 15 nm (  ). 
From these data, it is clear that a minimum in buoyancy is 
observed for all systems as the large oil core volume 
dominates for high droplet/capsule sizes and the metal 
components of the surface (Pt-NPs and secondary gold shell) 
dominates for low droplet/capsules sizes. Thus, we expect 
that it is possible to separate the smallest Pickering emulsion 
droplets from droplets around 600 nm and above in these 
particular emulsion samples.  
Equation 1 represents a version of Stokes law modified to be 
specifically applicable to a Pickering emulsion droplet 
travelling in a liquid under a centrifugal force (see 
supplementary information S1 for derivation). This equation 
was used to calculate settling time of the smallest droplets for 
a particular centrifugal speed in order to design an experiment 
where a broad size distribution can be split into the creaming 
and sedimenting populations. 
𝑡 = 18𝜇𝑙𝑛 (𝑅𝑓 𝑅𝑖⁄ )𝐷𝑒2𝜔2 ((4𝛽𝜌𝑛𝑝𝐷𝑛𝑝𝐷𝑒 + 𝜌𝑜𝑖𝑙) − 𝜌𝑓) 
Equation 1 
Where: 𝐷𝑒  Pickering emulsion drop diameter (m), 𝛽 2D fractional 
nanoparticle surface area coverage on the emulsion drop surface, 𝐷𝑛𝑝 
nanoparticle metal core diameter (m), 𝜇 fluid dynamic viscosity (Pa.s), 𝑅𝑓  final radius of rotation (m), 𝑅𝑖  initial radius of rotation (m), 𝜌𝑛𝑝 nanoparticle metal core density (kg/m³), 𝜌𝑜𝑖𝑙 emulsion drop oil density 
(kg/m³), 𝜌𝑓 continuous phase density (kg/m³), ω is the angular 
velocity (radian/s), 𝑡 time to sediment from 𝑅𝑖  to 𝑅𝑓  (s). 
Cryo-TEM was used in conjunction with particle counting 
software (imageJ) to measure the average Pt-NP core 2D 
densities on the surface of the Pickering emulsion droplets 
produced here and to verify that high Pt-NP densities are 
achieved. The mean Pt-NP core density was measured to be 
~34% and was shown to be independent of Pickering 
emulsion drop size. High particle surface coverage is 
expected based on previously measured densities at 
liquid/solid interface.[33],[36] 
Figure 7a demonstrates the possibility of separating the 
Pickering emulsion droplets into two populations via 
centrifugation. The graph shows three size distributions for 
the original Pickering emulsion and the separated (creamed 
and sedimented) emulsion layers post centrifugation. 
 
Figure 7a shows a graph of size distributions measured by DLS. The 3 size 
distributions represent the original Pickering emulsion and the creamed and 
sedimented layers post centrifugation, (b) are photographs of the Pickering 
emulsion pre and post centrifugation (note that the creamed layer appears 
lower than the liquid surface due to the angle at which the tubes were 
centrifuged) 
As predicted from Figure 6, the Pickering emulsion droplets 
separated by size with larger droplets creaming and sub ~600 
nm droplets sedimenting. Importantly, after centrifugation, it 
was possible to easily redisperse the small Pickering emulsion 
droplets (as seen in Figure 7a from the subsequent size 
distribution measurement) for deposition of the secondary 
gold films. 
The system which allowed for the production of the smallest 
droplet sizes was thus chosen and used in the following 
section as a template for secondary metal film growth by 
electroless deposition.  
Fine control over secondary metal film growth 
In order to understand secondary metal film growth onto the 
Pickering ‘nanoemulsion’ droplets, we first tested the 
achievable control of secondary metal deposition on freely 
dispersed Pt-NPs (Fig. 8a to 8e). The mass of gold salt 
required to grow the Pt-NP ‘seeds’ from their original mean 
size of approximately 3 nm to larger diameters up to 6 nm 
was first calculated. Final particle sizes were specifically 
chosen to be approximately half the mean inter-nanoparticle 
spacing on the Pickering ‘nanoemulsion’ surface (~12 nm, 
measured by Cryo-TEM). 
Subsequently, the Pickering ‘nanoemulsion’ droplets were 
used to understand and tightly control the early stage 
secondary film growth (Fig. 8f to 8j). This study was 
conducted with the long-term aim of reproducibly producing 
ultra-thin, continuous metal films onto such small droplets to 
maximise the core content of the resulting ‘nanocapsules’. 
The measured Pt-NP density at the droplet interface was 
again used here to assess the minimum mass of gold required 
to bridge the mean Pt-NP core inter-particle spacing 
(excluding the PVP stabilising layer) with the growing gold 
film, which allow for precisely tuning the gold salt 
concentration in the electroless deposition process. Thus, in 
targeting very thin gold films, we also use Cryo-TEM to 
characterise the early stage of the secondary metal film 
growth on the Pickering nano-sized emulsion droplet surface. 
Figure 8 (a-j) show nanoparticle dispersions at the same 
concentration either as a free dispersion or on a Pickering 
nano-sized emulsion droplet surface. (a) shows the original 
Pt-NP and (b-e) show progressively larger platinum core, 
gold shell particles. (a* and d*) show TEM micrographs of the 
nanoparticles in (a) and (d) respectively. Figure 8(f-j) show 
the corresponding Pickering nano-sized emulsions. 
  
 
Figure 8 (a-j) show nanoparticle dispersions at the same concentration 
either as a free dispersion or on a Pickering emulsion droplet surface (200 
times dilution of the original Pt-NP dispersion (see methods)). (a) shows 
the original Pt-NP and (b-e) show progressively larger platinum and gold 
core / shell particles. (a* and d*) show TEM micrographs of the 
nanoparticles in (a) and (d) respectively. (f- j) show the corresponding 
Pickering nano-sized emulsions. 
It is interesting to note the shift towards the shorter 
wavelengths (Figure 8h-i). The colour change from red to 
blue which deviates from the colours of the series of free 
nanoparticle samples (Figure 8a-e) would appear to mark the 
onset of film formation as the growing nanoparticle Pickering 
emulsion ‘sheet’ becomes a full film. Thin sputter coated gold 
films have been shown to appear blue in transmitted light.[37] 
Figure 9 shows a graph of nanoparticle diameter, as measured 
by TEM of the nanoparticles shown in Figure 8a-e, as a 
function of the mass of gold added. The red dot shows the 
mean nanoparticle size measured by cryo-TEM on the 
equivalent Pickering nano-sized emulsion droplet interfaces. 
 
Figure 9 Nanoparticle diameter, as measured by TEM of the nanoparticles 
shown in Figure 8, as a function of the mass of gold added. The red dot 
shows the mean nanoparticle size measured on nano Pickering emulsion 
drop interfaces, grown in the same way as the free Pt-NPs. The continuous 
line represents a fit calculated from the mass of gold salt and the number 
and mean size of the Pt-NPs used (see equation S4 in the supplementary 
information). 
We can see from Figure 9 that the size of the nanoparticles 
associated with the Pickering nano-sized emulsion droplet 
surface fit well with those in the free dispersion. The 
continuous line represents a fit calculated from the mass of 
gold salt used to grow the underlying Pt-NP cores and the 
number and mean size of the Pt-NPs used (see equation S4 in 
the supplementary information). The under prediction of the 
fit at larger composite Pt core, Au shell nanoparticle 
diameters may be due to non-spherical deviation which was 
assumed in the calculations. Figure 10 shows the 
corresponding cryo-TEM micrographs of examples of both 
the original Pickering nano-sized emulsion interface and one 
where the nanoparticles have been grown to a mean diameter 
of 6 nm. 
 
Figure 10 Cryo-TEM micrographs showing the Pt-NP spacing on nano-
Pickering emulsion droplets before and after gold growth. Samples are 
taken from dispersions (a) and (d) pictured in Figure 11. 
This provides exquisite control over the very early secondary 
film thickness (~3-6 nm) and allows for the production of 
films which are independent of both Picking nanno-sized 
emulsion size distribution and the number of excess Pt-NPs 
in the continuous phase (note that the emulsions used here are 
designed to form with little or no nanoparticles left over in the 
continuous phase and therefore we expect very few to be 
present, as evidenced by the low number of free nanoparticles 
visible in the amorphous water cryo-TEM image 
backgrounds (Figure 5b and Figure 11a)).  
 
Figure 11 shows cryo-TEM images of a Pickering nano-sized 
emulsion drop with successively thicker gold films on their 
surfaces (Figure 11a-c). Although the images were chosen 
from polydisperse samples it should be notes that secondary 
gold film growth is independent from the underlaying droplet 
diameter and therefore any chosen capsules surface structure 
should be representative, (d) shows a wider field Cryo-TEM 
image of  the sample (b) was chosen from.  
 
Figure 11 shows CryoTEM images of  (a) a nanoPickering emulsion drop 
with (b and c) successively thicker gold films on its surface. Images were 
chosen from a more polydisperse samples, (d)  shows a more representave 
wider field CryoTEM image of  the sample (b) was chosen from.  
Interestingly, as the distance between the growing 
nanoparticles on the Pickering nano-sized emulsion surface 
reduced, and they came into close proximity, the growth 
became somewhat inhomogeneous and therefore films 
needed to be grown thicker than the theoretical minimum (on 
the basis of the inter-nanoparticle spacing) in order to achieve 
complete coverage. This is likely due to Ostwald ripening 
occurring when the growing nanoparticle size differential 
becomes significant. These initial observations match reports 
from the literature that suggest metal nanoparticle seeded 
growth of homogeneous thin (less than 20 nm) complete 
metal films is difficult to achieve.[38-41] At close range, 
surface atoms are more readily able to migrate or even desorb 
and redeposit on a different surface[42] thus lowering local 
surface energies and therefore surface area volume ratios. 
Nanocapsule core retention 
Finally, we demonstrate that the resulting nanocapsules are 
able to retain a small model molecule in a continuous phase 
in which the core readily dissolves, a characteristic previously 
demosntrated for micron-sized capsules.[30-32] 
Figure 12 introduces data for core release over time as 
measured by GC for both the uncoated Pickering 
nanoemulsion droplets and the metal coated nanocapsules. 
 
Figure 12: Hexadecane core release (molecular weight comparable to that 
of most cancer drugs – 226 g.mol-1) into ethanol/water (4:1) for the nano 
Pickering emulsion droplets (  ) and metal-nano nanocapsules ( ). The 
last data point ( ) demonstrates release achieved from the metal nano-
capsules when initiating metal film fracture using an ultrasonic probe. 
The uncoated Pickering emulsion droplets released 100% of 
their core into the ethanol:water (4:1) continuous phase 
quickly as would be expected, given the very large surface to 
volume ratio, porosity of the Pt-NP film to hexadecane and 
the solubility of hexadecane in the continuous phase. For 
similar reasons, we would expect any incomplete metal 
shelled nanocapsule to release their core fully and quickly. 
The ~65% oil retention for 6 hours seen for the metal coated 
nanoemulsions shows that a large proportion of these 
nanocapsules achieve permanent encapsulation in this 
sample. An ultrasonic probe was then used to fracture and 
release the remaining oil. Through this process a further 
~15% of the core hexadecane is released, demonstrating that 
oil has indeed been encapsulated efficiently within these 
metal-coated nanocapsules. Not all the core hexadecane is 
retrieved in these measurements, which indicates that only a 
proportion of the nanocapsule metal films are ruptured under 
these sonication conditions. 
1.4 Conclusions 
We demonstrate a method that adapts our previously 
developed production of metal microcapsules to achieve 
much smaller nano-sized capsules with the objective of 
creating impermeable capsules that can be circulated 
intravenously. 
In this work, we firstly demonstrate that the size of the 
Pickering emulsion precursor can be controlled by limiting 
the total amount of interface created by the high-energy 
emulsification process through varying the oil to water ratio 
in the emulsion for a fixed number of nanoparticle stabilisers. 
Subsequently, we develop a mathematical model to predict 
the separation of the nano-Pickering emulsion based on their 
size when centrifugation is used. This model is then verified 
experimentally, which leads to Pickering nano-sized 
emulsion precursors that can be used to prepare metal-shell 
capsules of appropriate dimensions for the intended 
application. In addition, by replicating gold shell growth on 
free Pt-NPs in suspension, we verify that the early stages of 
gold film growth on Pickering emulsion stabilized with the 
same Pt-NPs leads to films of equivalent thicknesses. 
However, it is clear that the proximity of the nanoparticles at 
the oil-water interface influences the early stage growth and 
more fundamental studies at these very short reaction times 
need to be carried out to understand how to obtain very thin, 
impermeable metal films via electroless deposition.  
Nevertheless, our study demonstrates that a typical cancer 
drug molecule can be retained indefinitely within larger metal 
microcapsules and that a model small molecule can also be 
permanently retained and released using an ultrasonic probe 
from metal nanocapsules. 
This work illustrates the potential of such metal nanocapsules 
for safely circulating highly potent drugs within the blood 
stream without undesired drug leaching prior to inducing 
localised release via ultrasounds. 
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